Effect of protease inhibitors on HIV-1 maturation and infectivity

This publication has 12 references indexed in Scilit:

• Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology
  Antimicrobial Agents and Chemotherapy, 1997
• Antiviral Activity of DG-35-VIII, a Potent Inhibitor of the Protease of Human Immunodeficiency Virus
  Antiviral Chemistry and Chemotherapy, 1997
• HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
  Science, 1996
• AC₂Symmetry-Based HIV Protease Inhibitor, A77003, Irreversibly Inhibits Infectivity of HIV-1In Vitro
  AIDS Research and Human Retroviruses, 1994
• Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
  Antimicrobial Agents and Chemotherapy, 1992
• Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor
  Archiv für die gesamte Virusforschung, 1991
• Rational Design of Peptide-Based HIV Proteinase Inhibitors
  Science, 1990
• A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation
  Science, 1990
• Active human immunodeficiency virus protease is required for viral infectivity.
  Proceedings of the National Academy of Sciences, 1988
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970